featured
Association of BMI, Lipid-Lowering Medication, and Age With Prevalence of Type 2 Diabetes in Adults With Heterozygous Familial Hypercholesterolaemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Diabetes & Endocrinology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
Lancet Diabetes Endocrinol 2024 Oct 03;[EPub Ahead of Print], European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC)From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.